You have 9 free searches left this month | for more free features.

Interleukin-12

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Washington, District of Columbia
  • +1 more
Mar 25, 2022

Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)

Suspended
  • Triple Negative Breast Cancer
  • Anthracycline-refractory TNBC
  • Houston, Texas
    Houston Methodist Cancer Center
Mar 28, 2022

NSCLC Trial in Houston (Atezolizumab and Interleukin-12 Gene Therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Atezolizumab and Interleukin-12 Gene Therapy
  • Houston, Texas
    Houston Methodist Cancer Center
Mar 9, 2022

Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Active, not recruiting
  • Prostate Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Health System
Feb 17, 2022

HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

Recruiting
  • HIV-1-infection
  • INO-6160, 2 mg
  • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
  • New York, New York
  • +2 more
Apr 13, 2023

Basal Cell Carcinoma Trial in Ljubljana (phIL12 GET)

Recruiting
  • Basal Cell Carcinoma
  • phIL12 GET
  • Ljubljana, Slovenia
  • +1 more
Nov 8, 2022

Metastatic Pancreatic Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Completed
  • Metastatic Pancreatic Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Hospital
Feb 15, 2022

HIV Trial in Chicago, Durham, Galveston (Interleukin-12, HIV-1 C4-V3 Polyvalent Peptide Vaccine)

Completed
  • HIV Infections
  • Interleukin-12
  • HIV-1 C4-V3 Polyvalent Peptide Vaccine
  • Chicago, Illinois
  • +2 more
Oct 28, 2021

HIV Trial in United States (Interleukin-12)

Completed
  • HIV Infections
  • Interleukin-12
  • Los Angeles, California
  • +15 more
Oct 27, 2021

Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)

Recruiting
  • Hematologic and Lymphocytic Disorder
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Placebo Administration
  • +3 more
  • Duarte, California
  • +3 more
Dec 14, 2022

Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

Active, not recruiting
  • Human Papillomavirus-16 Positive
  • +20 more
  • DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
  • Durvalumab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 11, 2022

HIV Trial in United States (PENNVAX®-GP HIV-1 DNA vaccine, Interleukin-12 (IL-12) DNA adjuvant, Placebo)

Completed
  • HIV Infections
  • PENNVAX®-GP HIV-1 DNA vaccine
  • +2 more
  • Decatur, Georgia
  • +3 more
Oct 13, 2021

HIV Trial in San Diego, Aurora, Indianapolis (Indinavir sulfate, Lamivudine/Zidovudine, Hepatitis A Vaccine (Inactivated))

Completed
  • HIV Infections
  • Indinavir sulfate
  • +6 more
  • San Diego, California
  • +2 more
Oct 27, 2021

Acute Myeloid Leukemia Trial in Toronto (IL-12)

Recruiting
  • Acute Myeloid Leukemia
  • IL-12
  • Toronto, Ontario, Canada
    Princess Margaret Centre Centre
Apr 16, 2021

Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

Active, not recruiting
  • Chronic Hepatitis
  • Hepatitis C Infection
  • Electroporation-Mediated Plasmid DNA Vaccine Therapy
  • +4 more
  • Jacksonville, Florida
  • +4 more
Sep 20, 2022

Crohn Disease Trial in Evansville (JNJ-64304500, Placebo, Adalimumab)

Withdrawn
  • Crohn Disease
  • Evansville, Indiana
    Medisphere Medical Research Center, Llc
Aug 30, 2021

HIV Trial in United States (Profectus HIV MAG pDNA vaccine, IL-12, Placebo)

Completed
  • HIV Infections
  • Profectus HIV MAG pDNA vaccine
  • +2 more
  • Los Angeles, California
  • +12 more
Oct 28, 2021

Solid Tumors Trial in France, United States (MEDI9253, Durvalumab)

Recruiting
  • Solid Tumors
  • MEDI9253
  • Durvalumab
  • La Jolla, California
  • +19 more
Jul 28, 2022

Crohn Disease Trial in China (Ustekinumab)

Recruiting
  • Crohn Disease
  • Beijing, China
  • +28 more
Aug 17, 2022

Metastatic Cancer Trial in Madison (interleukin-12 gene)

Terminated
  • Metastatic Cancer
  • interleukin-12 gene
  • Madison, Wisconsin
    University of Wisconsin Comprehensive Cancer Center
Dec 12, 2019

Glioblastoma, Glioma, Tumors, Neuroepithelial Trial in Hangzhou (Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12,

Recruiting
  • Glioblastoma
  • +7 more
  • Dendritic Cell/Tumor Fusion Vaccine
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 7, 2020

Kidney Tumor, Lung Tumor, Sarcoma Trial run by the NCI (rh IL-12, rh IL-2)

Terminated
  • Kidney Neoplasm
  • +3 more
  • rh IL-12
  • rh IL-2
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Psoriatic Arthritis Trial in Germany, Netherlands, United Kingdom (AIN457A, Other)

Completed
  • Psoriatic Arthritis
  • AIN457A
  • Other
  • Hamburg, Germany
  • +5 more
May 26, 2021

Melanoma Trial in United States (Tavokinogene Telseplasmid (tavo), OncoSec Medical System (OMS))

Completed
  • Melanoma
  • Tavokinogene Telseplasmid (tavo)
  • OncoSec Medical System (OMS)
  • San Francisco, California
  • +5 more
Oct 1, 2019

Atopic Dermatitis, Immunoglobulin E Concentration, Serum Trial in Jakarta Pusat (Cimetidine, Placebos)

Unknown status
  • Atopic Dermatitis
  • Immunoglobulin E Concentration, Serum
  • Jakarta Pusat, Jakarta, Indonesia
    Faculty of Medicine Universitas Indonesia
Oct 2, 2019